Variant report

Variant	esv3424622
Chromosome Location	chr7:103628741-103631589
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:260)
CpG islands
(count:857)
Chromatin interactive
region (count:6)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:260 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr7:103630735-103631071	HepG2	liver:	n/a	n/a
2	BACH1	chr7:103630403-103630841	H1-hESC	embryonic stem cell:	n/a	n/a
3	BHLHE40	chr7:103630955-103631170	K562	blood:	n/a	n/a
4	BHLHE40	chr7:103630242-103630465	K562	blood:	n/a	n/a
5	BRCA1	chr7:103630409-103630501	HepG2	liver:	n/a	n/a
6	CBX3	chr7:103631526-103632218	K562	blood:	n/a	n/a
7	CBX3	chr7:103630124-103631002	K562	blood:	n/a	n/a
8	CCNT2	chr7:103628934-103630862	K562	blood:	n/a	n/a
9	CEBPB	chr7:103631468-103632206	HepG2	liver:	n/a	n/a
10	CEBPB	chr7:103631466-103631600	K562	blood:	n/a	n/a
11	CEBPD	chr7:103629850-103630399	HepG2	liver:	n/a	n/a
12	CHD2	chr7:103630309-103630405	K562	blood:	n/a	n/a
13	CHD2	chr7:103630883-103631112	HepG2	liver:	n/a	n/a
14	CHD2	chr7:103629490-103629707	HepG2	liver:	n/a	n/a
15	CHD2	chr7:103629930-103630104	K562	blood:	n/a	n/a
16	CHD2	chr7:103631274-103631279	K562	blood:	n/a	n/a
17	CHD2	chr7:103629362-103629637	K562	blood:	n/a	n/a
18	CTBP2	chr7:103628930-103629720	H1-hESC	embryonic stem cell:	n/a	n/a
19	CTBP2	chr7:103629941-103630727	H1-hESC	embryonic stem cell:	n/a	n/a
20	CTCF	chr7:103630520-103630670	GM12875	blood:	n/a	n/a
21	CTCF	chr7:103630640-103630790	HRE	kidney:	n/a	n/a
22	CTCF	chr7:103630600-103630750	AG09319	gingival:	n/a	n/a
23	CTCF	chr7:103630560-103630710	HBMEC	blood vessel:	n/a	n/a
24	CTCF	chr7:103630540-103630690	GM12872	blood:	n/a	n/a
25	CTCF	chr7:103630520-103630670	HAc	cerebellar:	n/a	n/a
26	CTCF	chr7:103630560-103630710	AG09319	gingival:	n/a	n/a
27	CTCF	chr7:103630613-103630680	LNCaP	prostate:	n/a	n/a
28	CTCF	chr7:103629300-103629450	SK-N-SH_RA	brain:	n/a	n/a
29	CTCF	chr7:103631000-103631150	HBMEC	blood vessel:	n/a	chr7:103631111-103631124
30	CTCF	chr7:103630574-103630627	GM13977	blood:	n/a	n/a
31	CTCF	chr7:103630480-103630630	SK-N-SH_RA	brain:	n/a	n/a
32	CTCF	chr7:103630431-103630795	K562	blood:	n/a	n/a
33	CTCF	chr7:103630586-103630697	GM19238	blood:	n/a	n/a
34	CTCF	chr7:103630520-103630670	HPAF	blood vessel:	n/a	n/a
35	CTCF	chr7:103630560-103630710	Caco-2	colon:	n/a	n/a
36	CTCF	chr7:103630520-103630670	AoAF	blood vessel:	n/a	n/a
37	CTCF	chr7:103630600-103630750	HFF-Myc	foreskin:	n/a	n/a
38	CTCF	chr7:103630500-103630650	WERI-Rb-1	eye:	n/a	n/a
39	CTCF	chr7:103630560-103630710	GM12865	blood:	n/a	n/a
40	CTCF	chr7:103630395-103630839	K562	blood:	n/a	chr7:103630402-103630415
41	CTCF	chr7:103630544-103630713	MCF-7	breast:	n/a	n/a
42	CTCF	chr7:103630560-103630710	GM12869	blood:	n/a	n/a
43	CTCF	chr7:103629860-103630010	SK-N-SH_RA	brain:	n/a	n/a
44	CTCF	chr7:103630500-103630650	HMF	breast:	n/a	n/a
45	CTCF	chr7:103630540-103630690	GM12871	blood:	n/a	n/a
46	CTCF	chr7:103630540-103630690	HRPEpiC	eye:	n/a	n/a
47	CTCF	chr7:103630573-103630721	A549	lung:	n/a	n/a
48	CTCF	chr7:103630640-103630790	GM12865	blood:	n/a	n/a
49	CTCF	chr7:103630600-103630750	WI-38	lung:	n/a	n/a
50	CTCF	chr7:103630545-103630760	HepG2	liver:	n/a	n/a

(count:857 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:103631052-103631102	HRCEpiC	kidney:	n/a
2	chr7:103630810-103630860	ProgFib	skin:	n/a
3	chr7:103629555-103629605	SK-N-SH	brain:	n/a
4	chr7:103631052-103631102	HRCEpiC	kidney:	n/a
5	chr7:103630810-103630860	ProgFib	skin:	n/a
6	chr7:103629555-103629605	SK-N-SH	brain:	n/a
7	chr7:103629555-103629605	MCF10A-Er-Src	breast:	n/a
8	chr7:103630013-103630063	BJ	skin:	n/a
9	chr7:103630549-103630599	GM12892	blood:	n/a
10	chr7:103630086-103630136	RPTEC	kidney:	n/a
11	chr7:103631129-103631179	HMEC	breast:	n/a
12	chr7:103629618-103629668	HNPCEpiC	eye:	n/a
13	chr7:103630490-103630540	HEEpiC	esophagus:	n/a
14	chr7:103631129-103631179	H1-hESC	embryonic stem cell:	embryo
15	chr7:103630490-103630540	ovcar-3	ovarian:	n/a
16	chr7:103631129-103631179	HCM	heart:	n/a
17	chr7:103629555-103629605	GM12891	blood:	n/a
18	chr7:103631129-103631179	HL-60	blood:	n/a
19	chr7:103629555-103629605	LNCaP	prostate:	n/a
20	chr7:103631052-103631102	ovcar-3	ovarian:	n/a
21	chr7:103629370-103629420	LNCaP	prostate:	n/a
22	chr7:103630490-103630540	HCM	heart:	n/a
23	chr7:103630989-103631039	SKMC	muscle:	n/a
24	chr7:103629618-103629668	BE2_C	brain:	n/a
25	chr7:103630013-103630063	HPAEpiC	pulmonary alveolar:	n/a
26	chr7:103629618-103629668	NHDF-neo	bronchial:	n/a
27	chr7:103630857-103630907	PrEC	prostate:	n/a
28	chr7:103629555-103629605	HNPCEpiC	eye:	n/a
29	chr7:103631129-103631179	NHDF-neo	bronchial:	n/a
30	chr7:103631129-103631179	SAEC	small airway:	n/a
31	chr7:103630549-103630599	Jurkat	blood:	n/a
32	chr7:103630093-103630143	Hepatocyte	liver:	n/a
33	chr7:103630013-103630063	SK-N-MC	brain:	n/a
34	chr7:103629618-103629668	GM19239	blood:	n/a
35	chr7:103630013-103630063	ECC-1	luminal epithelium:	n/a
36	chr7:103631129-103631179	HRE	kidney:	n/a
37	chr7:103630093-103630143	HPAEpiC	pulmonary alveolar:	n/a
38	chr7:103630086-103630136	NT2-D1	testis:	n/a
39	chr7:103630013-103630063	MCF10A-Er-Src	breast:	n/a
40	chr7:103629370-103629420	NT2-D1	testis:	n/a
41	chr7:103630989-103631039	NHBE	bronchial:	n/a
42	chr7:103630857-103630907	IMR90	lung:	fetal
43	chr7:103631052-103631102	GM12878	blood:	n/a
44	chr7:103630989-103631039	HCT-116	colon:	n/a
45	chr7:103631129-103631179	ovcar-3	ovarian:	n/a
46	chr7:103629618-103629668	GM12878	blood:	n/a
47	chr7:103630083-103630133	SK-N-MC	brain:	n/a
48	chr7:103630490-103630540	AoSMC	blood vessel:	n/a
49	chr7:103629618-103629668	AG04450	lung:	fetal
50	chr7:103630810-103630860	HRPEpiC	eye:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr7:103507537..103509720-chr7:103630698..103632268,2	K562	blood:
2	chr7:103630552..103631385-chr7:103736876..103737824,2	K562	blood:
3	chr7:103628555..103630772-chr7:103847007..103849982,2	K562	blood:
4	chr7:103507537..103509850-chr7:103630768..103632439,2	K562	blood:
5	chr7:103630477..103632147-chr7:103644604..103646445,2	K562	blood:
6	chr7:103559740..103561344-chr7:103627840..103629599,2	K562	blood:

No data

Variant related genes	Relation type
RELN	TF binding region
RELN	CpG island
ENSG00000164815	chromatin interactions

Extended variants
information (count: 98 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:98 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs557151870	chr7:103628787-103628788	Weak transcription Active TSS Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs73405690	chr7:103628844-103628845	Enhancers Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs146716707	chr7:103628876-103628877	Enhancers Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs371093542	chr7:103628936-103628937	Enhancers Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs557283341	chr7:103628992-103628993	Enhancers Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs115458906	chr7:103629011-103629012	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs546799857	chr7:103629028-103629029	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs78597830	chr7:103629036-103629037	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs553247951	chr7:103629079-103629080	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs575105862	chr7:103629083-103629084	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs542042680	chr7:103629103-103629104	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs111931178	chr7:103629105-103629106	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs113171616	chr7:103629116-103629117	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs575622982	chr7:103629172-103629173	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs549154269	chr7:103629178-103629179	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs567364142	chr7:103629181-103629182	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs77049477	chr7:103629203-103629204	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs564434778	chr7:103629225-103629226	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs529372461	chr7:103629242-103629243	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs114500395	chr7:103629251-103629252	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs547042675	chr7:103629273-103629274	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs547602067	chr7:103629287-103629288	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs566062185	chr7:103629303-103629304	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs539486734	chr7:103629309-103629310	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs529202141	chr7:103629455-103629456	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs550471782	chr7:103629492-103629493	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs569035777	chr7:103629493-103629494	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs539104783	chr7:103629511-103629512	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs199505264	chr7:103629529-103629530	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs187966460	chr7:103629533-103629534	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs201725447	chr7:103629549-103629550	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs368498253	chr7:103629555-103629556	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs201261973	chr7:103629562-103629563	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs369454305	chr7:103629570-103629571	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs555377051	chr7:103629581-103629582	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs370805443	chr7:103629615-103629616	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs372475867	chr7:103629650-103629651	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs139648092	chr7:103629665-103629666	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs375165806	chr7:103629674-103629675	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs369522512	chr7:103629677-103629678	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs149715692	chr7:103629691-103629692	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs144557847	chr7:103629727-103629728	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs370745351	chr7:103629736-103629737	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs139532757	chr7:103629739-103629740	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs145135688	chr7:103629745-103629746	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs557229008	chr7:103629748-103629749	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs147551940	chr7:103629764-103629765	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs115165703	chr7:103629778-103629779	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs536610894	chr7:103629803-103629804	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs398124189	chr7:103629804-103629805	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Basal cell lymphoma	17170743	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Non-small cell lung cancer	21829676	CNVD
Gastric cancer	24379144	CNVD
Glioblastoma multiforme	17002787	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lissencephaly	21572526	CNVD
Breast cancer	17603634	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Metanephric adenoma	20802469	CNVD
Prostate cancer	16461572	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
Malignant melanoma	17260012	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Chronic myeloid leukemia	21384125	CNVD
Bladder cancer	21909424	CNVD
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	16608533	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Liver carcinoma	19366792	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Adenocarcinoma	19607727	CNVD
Multiple myeloma	16461302	CNVD
Breast cancer	21858162	CNVD
Emphysema	19352772	CNVD
Effusion lymphoma	18079361	CNVD
Medulloblastoma	17653508	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Autism	19401682	CNVD
Neuroticism	17667963	CNVD
Prostate cancer	18632612	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	19907438	CNVD
Breast cancer	21364760	CNVD
abnormal development	18461090	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	21147910	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:378 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:103626600-103629000	Active TSS	HepG2	liver
2	chr7:103628200-103629000	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
3	chr7:103628400-103628800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
4	chr7:103628600-103629600	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
5	chr7:103628600-103630800	Active TSS	K562	blood
6	chr7:103628800-103629000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
7	chr7:103628800-103629000	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
8	chr7:103628800-103629000	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
9	chr7:103628800-103629000	Bivalent/Poised TSS	Fetal Muscle Leg	muscle
10	chr7:103628800-103629400	Active TSS	Liver	Liver
11	chr7:103628800-103630000	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr7:103628800-103631000	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
13	chr7:103629000-103629200	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr7:103629000-103629200	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
15	chr7:103629000-103629200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
16	chr7:103629000-103629200	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr7:103629000-103629200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
18	chr7:103629000-103629200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr7:103629000-103629200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
20	chr7:103629000-103629200	Bivalent Enhancer	Brain Hippocampus Middle	brain
21	chr7:103629000-103629200	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
22	chr7:103629000-103629200	Bivalent Enhancer	Fetal Heart	heart
23	chr7:103629000-103629200	Flanking Bivalent TSS/Enh	Psoas Muscle	Psoas
24	chr7:103629000-103629200	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle
25	chr7:103629000-103629200	Bivalent Enhancer	Stomach Smooth Muscle	stomach
26	chr7:103629000-103629200	Bivalent Enhancer	NHEK	skin
27	chr7:103629000-103629400	Flanking Bivalent TSS/Enh	IMR90 fetal lung fibroblasts Cell Line	lung
28	chr7:103629000-103629400	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
29	chr7:103629000-103629400	Bivalent Enhancer	Primary hematopoietic stem cells	blood
30	chr7:103629000-103629400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
31	chr7:103629000-103629400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
32	chr7:103629000-103629400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
33	chr7:103629000-103629400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
34	chr7:103629000-103629400	Bivalent Enhancer	Fetal Muscle Leg	muscle
35	chr7:103629000-103629600	Bivalent/Poised TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
36	chr7:103629000-103629600	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr7:103629000-103629600	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
38	chr7:103629000-103629600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
39	chr7:103629000-103629600	Enhancers	Pancreas	Pancrea
40	chr7:103629000-103629600	Active TSS	Right Atrium	heart
41	chr7:103629000-103629600	Bivalent/Poised TSS	HepG2	liver
42	chr7:103629000-103629800	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
43	chr7:103629000-103629800	Bivalent Enhancer	Fetal Brain Male	brain
44	chr7:103629000-103630600	Bivalent/Poised TSS	Fetal Brain Female	brain
45	chr7:103629000-103630800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
46	chr7:103629000-103630800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
47	chr7:103629000-103631000	Active TSS	Brain Anterior Caudate	brain
48	chr7:103629000-103631000	Bivalent/Poised TSS	Fetal Stomach	stomach
49	chr7:103629000-103631000	Bivalent/Poised TSS	NHLF	lung
50	chr7:103629000-103631200	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links